Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03679741 · ClinicalTrials.gov registry record · NA
Initial Evaluation of Investigational Lenses Manufactured on a New Production Line
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 126
- Enrollment target
NCT03679741 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 126 participants.
The verdict
NCT03679741, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 126 participants
- Enrollment target
Study Summary
This study is a randomized, 4-visit, subject-masked, 2x3 bilateral crossover, dispensing trial. Each study lens will be worn bilaterally in a daily wear (DW) modality for at least 6 hours per day and 5 days per week for approximately two weeks each. The subject will wear either the Test or Control lens twice and the other study lens once.
Interventions
- DEVICE CONTROL Lens
- DEVICE TEST Lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2018-08-29 |
| Est. Completion | 2018-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03679741
The ClinicalTrials.gov registry entry for NCT03679741 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CONTROL Lens is the first listed.
NCT03679741 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03679741 about?
NCT03679741 is a clinical study titled "Initial Evaluation of Investigational Lenses Manufactured on a New Production Line". This study is a randomized, 4-visit, subject-masked, 2x3 bilateral crossover, dispensing trial. Each study lens will be worn bilaterally in a daily wear (DW) modality for at least 6 hours per day and 5 days per week for approximately two weeks each. The subject will wear either the Test or Control l...
What is the current status of trial NCT03679741?
This trial is currently completed. It is a NA study. The enrollment target is 126 participants. The study started on 2018-08-29. Estimated completion is 2018-10-31.
What interventions are being tested in trial NCT03679741?
The interventions under investigation include: CONTROL Lens (DEVICE), TEST Lens (DEVICE).
Who is sponsoring clinical trial NCT03679741?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.